NDC 0078-0467-61 - Desferal
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0078-0467
- Requested NDC
- 0078-0467-61
- Package NDCs from labels
- 0078-0467-61, 0078-0467-91
- Manufacturer
- Novartis Pharmaceuticals Corporation
- Effective date
- 2025-06-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Desferal - Novartis Pharmaceuticals Corporation | Novartis Pharmaceuticals Corporation | 2025-06-17 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0078-0467-61 | Desferal | 1 in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 1 | 20 | |
| 0078-0467-91 | Desferal | 4 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 4 | 20 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0078-0467 | DESFERAL (DEFEROXAMINE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [NOVARTIS PHARMACEUTICALS CORPORATION] | 19 | Current NDC, Legacy NDC, 2 package rows | 20240723_a7174843-5965-49fc-b842-f7eff7b48bbc.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0078-0467-61 | EA - Each | 0078-0467 | fe219be8-6536-4d13-a82c-1d01fbfff383 | 1 | 2013-02-13 |
| 0078-0467-91 | EA - Each | 0078-0467 | b260a20c-2728-40fa-872f-66ff7efc01a1 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| DEFEROXAMINE MESYLATE | ACTIVE INGREDIENT | V9TKO7EO6K | DESFERAL (DEFEROXAMINE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [NOVARTIS PHARMACEUTICALS CORPORATION] | 7 | |
| DEFEROXAMINE | ACTIVE MOIETY | J06Y7MXW4D | DESFERAL (DEFEROXAMINE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [NOVARTIS PHARMACEUTICALS CORPORATION] | 7 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Deferoxamine | DEFEROXAMINE MESYLATE | Fresenius Kabi USA, LLC | d91e16df-8daa-4cd2-86a2-273eaa2446e0 | 2026-06-15 | Warnings, Adverse reactions | 1731350 V9TKO7EO6K |
| Deferoxamine mesylate | DEFEROXAMINE MESYLATE | Apotex Corp. | c99553fb-3fae-b88a-6c2c-efa7520197f9 | 2026-05-29 | Warnings, Adverse reactions | 1731350 V9TKO7EO6K |
| Deferoxamine Mesylate | DEFEROXAMINE MESYLATE | Hospira, Inc. | f9ab6b1c-98d0-4373-0e9b-b10cb4a67543 | 2026-04-06 | Warnings, Adverse reactions | 1731350 V9TKO7EO6K |
| Deferoxamine mesylate | DEFEROXAMINE MESYLATE | Gland Pharma Limited | 598fba68-f46e-4b6e-894c-63c2940b2063 | 2026-03-06 | Warnings, Adverse reactions | 1731350 V9TKO7EO6K |
| Desferal | DEFEROXAMINE MESYLATE | MITEM PHARMA | 38eff751-96c5-c48a-e063-6294a90a0e48 | 2025-07-02 | NDA016267 1731352 1731350 V9TKO7EO6K | |
| Desferal | DEFEROXAMINE MESYLATE | Novartis Pharmaceuticals Corporation | a7174843-5965-49fc-b842-f7eff7b48bbc | 2025-06-17 | Warnings, Adverse reactions | NDA016267 0078-0467-91 0078-0467-61 0078-0467 00078046761 1731352 1731350 9f58db85-c282-46eb-94ba-594e2092ddf2 a7174843-5965-49fc-b842-f7eff7b48bbc V9TKO7EO6K |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.